Want to see KR:192820 full AI Analyst Report?
192820 Stock Chart & Stats
$247000.00
-$1,000.00(-0.40%)
―
--
Day’s Range― - ―
52-Week Range$141,000.00 - $320,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)84.89K
Market Cap
₩2.80T
Enterprise Value$2.56T
Total Cash (Recent Filing)₩353.30B
Total Debt (Recent Filing)₩1.09T
Price to Earnings (P/E)14.6
Beta0.15
Next Earnings
Nov 16, 2026EPS Estimate
3,483.09Next Dividend Ex-DateN/A
Dividend Yield1.34%
Share Statistics
EPS (TTM)16944.17
Shares Outstanding11,349,509
10 Day Avg. Volume89,093
30 Day Avg. Volume84,887
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)3.31
Price to Sales (P/S)0.77
P/FCF Ratio-18.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₩370,000.00Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)15,238.71
Revenue Forecast (FY)₩3.05T
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthThe multiyear revenue increase indicates expanding demand for COSMAX’s cosmetics development and manufacturing services. Continued top-line growth can support operating scale, strengthen customer relationships, and provide a durable foundation for reinvestment across skincare, makeup, and personal care categories.
Improved ProfitabilityThe recovery from a net loss to positive and improving margins demonstrates stronger earnings execution and operating discipline. If maintained, higher profitability should improve internal funding capacity, support investment in research and development, and increase resilience across the business cycle.
R&D-Driven ODM Business ModelAn integrated, R&D-led contract manufacturing model embeds COSMAX in customers’ product development processes rather than limiting it to basic production. This breadth of service can reinforce customer relationships, support repeat business, and help the company participate in innovation across beauty categories.
Bears Say
Elevated LeverageHigh and rising leverage increases COSMAX’s sensitivity to financing costs and reduces balance-sheet flexibility. Greater debt obligations can constrain capital allocation and make it harder to absorb weaker operating conditions, even though returns and profitability have recently improved.
Weak Recent Cash ConversionLow operating cash conversion and repeated negative free cash flow indicate that reported earnings are not currently translating into equivalent financial resources. This can limit deleveraging, increase reliance on external funding, and restrict the company’s ability to finance growth internally.
Gross Margin PressureThe sustained gross-margin decline signals pressure before operating expenses and may reflect higher input costs or pricing pressure. If this trend persists, it could limit the benefit of revenue growth, make earnings more dependent on operating efficiency, and weaken long-term margin sustainability.
COSMAX, Inc. News
192820 FAQ
What was COSMAX, Inc.’s price range in the past 12 months?
COSMAX, Inc. lowest stock price was $141000.00 and its highest was $320000.00 in the past 12 months.
What is COSMAX, Inc.’s market cap?
COSMAX, Inc.’s market cap is ₩2.80T.
When is COSMAX, Inc.’s upcoming earnings report date?
COSMAX, Inc.’s upcoming earnings report date is Nov 16, 2026 which is in 16 days.
How were COSMAX, Inc.’s earnings last quarter?
COSMAX, Inc. released its earnings results on Aug 11, 2026. The company reported $4290.041 earnings per share for the quarter, beating the consensus estimate of $3947.22 by $342.821.
Is COSMAX, Inc. overvalued?
According to Wall Street analysts COSMAX, Inc.’s price is currently Undervalued.
Does COSMAX, Inc. pay dividends?
COSMAX, Inc. pays a Notavailable dividend of $3300 which represents an annual dividend yield of 1.34%. See more information on COSMAX, Inc. dividends here
What is COSMAX, Inc.’s EPS estimate?
COSMAX, Inc.’s EPS estimate is 3,483.09.
How many shares outstanding does COSMAX, Inc. have?
COSMAX, Inc. has 11,349,509 shares outstanding.
What happened to COSMAX, Inc.’s price movement after its last earnings report?
COSMAX, Inc. reported an EPS of $4290.041 in its last earnings report, beating expectations of $3947.22. Following the earnings report the stock price went up 3.194%.
Which hedge fund is a major shareholder of COSMAX, Inc.?
Currently, no hedge funds are holding shares in KR:192820
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMAX, Inc.
Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensive beauty product line features skincare formulations, decorative makeup, hair care essentials, and specialty treatments such as facial masks and under-eye patches. Beyond its cosmetic offerings, the company also develops and produces medical equipment and supplies, provides raw materials for cosmetic formulations, and manufactures advanced containers and filling packaging for cosmetics. Originally established as Miroto Korea, the company rebranded to Cosmax, Inc. in 1994. Founded in 1992, its primary corporate offices are located in Hwaseong, South Korea.
192820 Stock 12 Month Forecast
Average Price Target
$370,000
Technical Analysis
LG Household & Health Care
―
Aekyung Industrial Co., Ltd.
―
Cosmax BTI Inc.
―
KOLMAR KOREA CO. LTD
―
KolmarBNH Co., Ltd.
―